Gendius presents at American Society of Nephrology Conference
Diabetes technology innovator Gendius has presented research on its new data-driven tool to identify type-2 diabetes patients at higher risk of having reduced kidney function at the American...
Research shows Gendius’ models can identify high risk patients
Newly published research shows that Gendius’ models can identify which people with diabetes are at high risk of renal impairment
Research published in...
Gendius presents at European Association for the Study of Diabetes (EASD) conference
Gendius presents validation of Chronic Kidney Disease pre-screening models at European Association for the Study of Diabetes (EASD) conference
UK...
Gendius technology for diabetes risk prediction launched in the GCC
Gendius technology for diabetes risk prediction launched in the GCC through new AstraZeneca patient support app, Health Gate
A new digital health...
Gendius initiates GP Data Study
Gendius initiates GP data study to develop enhanced risk prediction tools for diabetes
UK medtech start-up Gendius has partnered with over 60 primary...
Gendius selected for Tech Nation’s Applied AI growth programme
Manchester-based healthtech innovator, Gendius, has been selected for Tech Nation’s Applied AI growth programme.
Gendius uses its sophisticated AI...
Gendius to collaborate with The University of Manchester on New Human-AI Research Teams.
Gendius are proud to be a part of the new Human-AI research teams developed by the University of Manchester to help cure humanity’s complex future health and societal problems through AI...
Gendius partners with the University of Nottingham to develop AI risk prediction technology
The project was awarded £250,000 of funding from Innovate UK.Digital health innovator, Gendius, has partnered with experts at the University of Nottingham’s Digital Research Service to develop...
Gendius defies COVID-19 with record growth
Manchester digital health start-up Gendius defies COVID-19 with record growth
Manchester-based digital health start-up Gendius has defied the odds for...
